Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
July 10, 2023 06:00 ET
|
Opthea Limited
MELBOURNE, Australia, July 10, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
Recombinant Coagulation Factors Market to be Worth $24.21 Billion by 2030 - Exclusive Report by Meticulous Research®
July 05, 2023 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, July 05, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Recombinant Coagulation Factors Market by Type (Factor VIII, Factor IX), Source (CHO, HEK),...
Novartis signs agreement to divest ‘front of eye’ ophthalmology assets in line with focused strategy
June 30, 2023 08:00 ET
|
Novartis Pharma AG
Divested assets to include Xiidra®, on-market treatment for dry eye disease and SAF312 (libvatrep), potential therapy for chronic ocular surface painDeal consistent with Novartis focused strategy of...
Synchrony’s CareCredit Integration with Nextech Expands Practice and Patient Financial Options
June 29, 2023 16:10 ET
|
Nextech Systems, Inc.
TAMPA, Fla., June 29, 2023 (GLOBE NEWSWIRE) -- Nextech, a complete healthcare technology solution for specialty providers, and Synchrony (NYSE: SYF), a premier consumer financial services provider,...
Medical Laser Market to Grow Rapidly at a CAGR of ~14.8% by 2030 | DataM Intelligence
June 29, 2023 10:00 ET
|
DataM Intelligence
New york, USA, June 29, 2023 (GLOBE NEWSWIRE) -- DataM Intelligence medical laser market insights report provides the current and forecast market analysis, individual leading medical laser...
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global
June 29, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 29, 2023 (GLOBE NEWSWIRE) -- CMS was included into the first “Sustainability Yearbook (China)” published by S&P Global. Nearly 1600 Chinese companies were included in the...
Despite Impressive Early Uptake of Apellis’ Syfovre in Geographic Atrophy, US Ophthalmologists Struggle to Articulate the Complement Inhibitor’s Value Proposition to Potential Patients
June 28, 2023 13:32 ET
|
Spherix Global Insights
Exton, Pennsylvania, June 28, 2023 (GLOBE NEWSWIRE) -- With the U.S. FDA approval of Apellis’ Syfovre (pegcetacoplan) on February 17th, 2023 for the treatment of geographic atrophy (GA), patients...
Global Ophthalmic Devices Market is expected to reach US$ 68.64 Billion in 2030
June 28, 2023 09:09 ET
|
ReportLinker
New York, June 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ophthalmic Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook,...
Dr. SriniVas R. Sadda Named 2023-2024 ARVO President Elect
June 27, 2023 09:00 ET
|
Doheny Eye Institute
PASADENA, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that SriniVas R. Sadda, MD, was named President Elect of...
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
June 26, 2023 06:15 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...